Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.34 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2913715 | 0.82 | KMT2A (0.42) | KMT2AATMALDH1A1PKMSLC1A2 | |
| SCHEMBL10620411 | 0.81 | KMT2A (0.33) | KMT2AATMALDH1A1PKM | |
| SCHEMBL3801263 | 0.77 | KMT2A (0.46) | KMT2AATMALDH1A1PKMSLC1A2 | |
| SCHEMBL4310967 | 0.77 | GSTK1 (0.37) | KMT2A | |
| SCHEMBL6687766 | 0.76 | ALDH1A1 (0.42) | KMT2AATMALDH1A1PKMSLC1A2 | |
| SCHEMBL10980060 | 0.76 | KMT2A (0.38) | KMT2AATMALDH1A1PKMSLC1A2 | |
| SCHEMBL825651 | 0.75 | LMNA (0.39) | KMT2AALDH1A1 | |
| SCHEMBL4302806 | 0.75 | LMNA (0.39) | KMT2AALDH1A1 | |
| SCHEMBL2011394 | 0.75 | ITGB3 (0.36) | KMT2AATMALDH1A1PKM | |
| SCHEMBL604671 | 0.73 | ALDH1A1 (0.56) | KMT2AATMALDH1A1PKMSLC1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 9272 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3389641-B1 | PROTEIN NANOCAPSULES WITH DETACHABLE ZWITTERIONIC COATING FOR PROTEIN DELIVERY | UNIV CALIFORNIA (US) | 2026-04-08 | — | — | EP | claimed |
| EP-3299383-B1 | SPECIFIC MODIFICATION OF ANTIBODY WITH IGG-BINDING PEPTIDE | UNIV KAGOSHIMA (JP) | 2025-12-03 | — | — | EP | claimed |
| US-12344635-B2 | COVID-19 vaccine | THE MEDICAL COLLEGE OF WISCONSIN, INC. (US) | 2025-07-01 | — | — | US | claimed |
| EP-4053556-B1 | MEASUREMENT SAMPLE PREPARATION METHOD, ANALYSIS METHOD, REAGENT, AND REAGENT KIT | SYSMEX CORP (JP) | 2025-05-21 | — | — | EP | claimed |
| WO-2025054602-A1 | PROTEIN FOR THE SEROLOGICAL DETECTION OF STREPTOCOCCUS EQUI SUBSPECIES EQUI EXPOSURE OR INFECTION | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2025-03-13 | — | — | WO | claimed |
| EP-3470418-B1 | SITE-SPECIFIC RADIOISOTOPE-LABELED ANTIBODY USING IGG-BINDING PEPTIDE | UNIV KAGOSHIMA (JP) | 2024-07-31 | — | — | EP | claimed |
| US-20210300970-A1 | COVID-19 VACCINE | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2021-09-30 | — | — | US | claimed |
| US-20200179503-A1 | GLYCOCONJUGATE VACCINES, PREPARATION METHOD AND USES THEREOF | Academia Sinica, Taipei, TAIWAN | 2020-06-11 | — | — | US | claimed |
| EP-3010534-B1 | PHARMACEUTICAL FORMULATIONS AND METHODS FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE INGREDIENT | TRANSGENE BIOTEK TLD (IN) | 2018-05-30 | — | — | EP | claimed |
| EP-2494075-B1 | TEMPLATED NANOCONJUGATES | UNIV NORTHWESTERN (US) | 2018-04-04 | — | — | EP | claimed |
| EP-0267204-B1 | IMMUNOPOTENTIATION | BIOENTERPRISES PTY LTD (AU) | 1993-12-08 | — | — | EP | claimed |
| EP-0220030-B1 | ORAL DELIVERY SYSTEM | BIOTECHNOLOGY AUSTRALIA PTY. LTD. (AU) | 1991-06-19 | — | — | EP | claimed |
| EP-0267204-A4 | IMMUNOPOTENTIATION. | BIOENTPR PTY LTD (AU) | 1989-03-22 | — | — | EP | claimed |
| EP-0267204-A1 | IMMUNOPOTENTIATION. | BIOENTERPRISES PTY LTD (AU) | 1988-05-18 | — | — | EP | claimed |
| WO-1987006590-A1 | IMMUNOPOTENTIATION | BIOENTERPRISES PTY. LTD. (AU) | 1987-11-05 | — | — | WO | claimed |
| EP-0220030-A2 | Oral delivery system | BIOTECHNOLOGY AUSTRALIA PTY. LTD. (AU) | 1987-04-29 | — | — | EP | claimed |
| WO-1987002251-A1 | ORAL DELIVERY OF BIOLOGICALLY ACTIVE SUBSTANCES BOUND TO VITAMIN B12, OR ANALOGUES THEREOF | BIOTECHNOLOGY AUSTRALIA PTY. LTD. (AU) | 1987-04-23 | — | — | WO | claimed |
| EP-0184710-A2 | Magnetic microspheres | BAYER AG (DE) | 1986-06-18 | — | — | EP | claimed |
| EP-0157797-A1 | DETECTING AN IMMUNOLOGICAL REACTION WITH ACTIVATED RED BLOOD CELLS (ERYTHROCYTES) | IMMUCOR, INC. (US) | 1985-10-16 | — | — | EP | claimed |
| WO-1985001354-A1 | DETECTING AN IMMUNOLOGICAL REACTION WITH ACTIVATED RED BLOOD CELLS (ERYTHROCYTES) | IMMUCOR, INC. (US) | 1985-03-28 | — | — | WO | claimed |